Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022

SELL
$193.77 - $244.14 $236,786 - $298,339
-1,222 Closed
0 $0
Q4 2021

Jan 25, 2022

BUY
$223.92 - $287.77 $18,137 - $23,309
81 Added 7.1%
1,222 $293,000
Q3 2021

Oct 20, 2021

BUY
$282.99 - $369.05 $11,602 - $15,131
41 Added 3.73%
1,141 $323,000
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $189,847 - $303,982
-733 Reduced 39.99%
1,100 $381,000
Q1 2021

Apr 29, 2021

BUY
$242.95 - $284.63 $5,101 - $5,977
21 Added 1.16%
1,833 $513,000
Q4 2020

Feb 04, 2021

SELL
$236.26 - $355.63 $226,573 - $341,049
-959 Reduced 34.61%
1,812 $443,000
Q3 2020

Oct 14, 2020

SELL
$264.77 - $305.71 $31,242 - $36,073
-118 Reduced 4.08%
2,771 $786,000
Q2 2020

Aug 06, 2020

BUY
$258.66 - $342.55 $12,157 - $16,099
47 Added 1.65%
2,889 $772,000
Q1 2020

Apr 21, 2020

SELL
$268.85 - $341.04 $16,937 - $21,485
-63 Reduced 2.17%
2,842 $899,000
Q4 2019

Jan 29, 2020

BUY
$220.06 - $304.07 $639,274 - $883,323
2,905 New
2,905 $862,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Beaumont Asset Management, L.L.C. Portfolio

Follow Beaumont Asset Management, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Asset Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Asset Management, L.L.C. with notifications on news.